Found: 15
Select item for more details and to access through your institution.
Effects of fluoxetine on dopamine D<sub>2</sub> receptors in the human brain: a positron emission tomography study with [<sup>11</sup>C]raclopride.
- Published in:
- International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 431, doi. 10.1017/s146114570400450x
- By:
- Publication type:
- Article
Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT2C receptor occupancy in rat brain.
- Published in:
- International Journal of Neuropsychopharmacology, 1999, v. 2, n. 2, p. 95, doi. 10.1017/s1461145799001406
- By:
- Publication type:
- Article
Measurement of Striatal D<sub>2</sub> Dopamine Receptor Density and Affinity with [<sup>11</sup>C]-Raclopride in Vivo: A Test-Retest Analysis.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 1999, v. 19, n. 2, p. 210, doi. 10.1097/00004647-199902000-00012
- By:
- Publication type:
- Article
Decrease in Human Striatal Dopamine D<sub>2</sub> Receptor Density with Age: A PET Study with [<sup>11</sup>C]Raclopride.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 1993, v. 13, n. 2, p. 310, doi. 10.1038/jcbfm.1993.39
- By:
- Publication type:
- Article
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man.
- Published in:
- Psychopharmacology, 2005, v. 182, n. 3, p. 375, doi. 10.1007/s00213-005-0092-6
- By:
- Publication type:
- Article
Ketamine does not decrease striatal dopamine D[sub 2] receptor binding in man.
- Published in:
- Psychopharmacology, 2002, v. 164, n. 4, p. 401, doi. 10.1007/s00213-002-1236-6
- By:
- Publication type:
- Article
Sertindole is a serotonin 5-HT[sub 2c] inverse agonist and decreases agonist but not antagonist binding to 5-HT[sub 2c] receptors after chronic treatment.
- Published in:
- Psychopharmacology, 2001, v. 157, n. 2, p. 180, doi. 10.1007/s002130100814
- By:
- Publication type:
- Article
The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system: A randomised placebo-controlled study on healthy volunteers.
- Published in:
- Psychopharmacology, 2001, v. 154, n. 4, p. 343
- By:
- Publication type:
- Article
Noradrenergic and dopaminergic effects of nomifensine in healthy volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 1987, v. 41, n. 1, p. 88, doi. 10.1038/clpt.1987.15
- By:
- Publication type:
- Article
Metabolism of nomifensine after oral and intravenous administration.
- Published in:
- Clinical Pharmacology & Therapeutics, 1986, v. 39, n. 4, p. 378, doi. 10.1038/clpt.1986.58
- By:
- Publication type:
- Article
Disposition of nomifensine after acute and prolonged dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 1986, v. 39, n. 4, p. 384, doi. 10.1038/clpt.1986.59
- By:
- Publication type:
- Article
Receptor binding profile and anxiolytic-type activity of deramciclane (EGIS-3886) in animal models.
- Published in:
- Drug Development Research, 1997, v. 40, n. 4, p. 333, doi. 10.1002/(SICI)1098-2299(199704)40:4<333::AID-DDR7>3.0.CO;2-K
- By:
- Publication type:
- Article
Brain 5-HT[sub 2A] receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study.
- Published in:
- Psychopharmacology, 1999, v. 145, n. 1, p. 76, doi. 10.1007/s002130051034
- By:
- Publication type:
- Article
Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT[sub 2C] receptor inverse agonist but fails to induce 5-HT[sub 2C] receptor down-regulation.
- Published in:
- Psychopharmacology, 1998, v. 136, n. 2, p. 99
- By:
- Publication type:
- Article
Effects of lorazepam administration on striatal dopamine D[sub 2] receptor binding characteristics in man - a positron emission tomography study.
- Published in:
- Psychopharmacology, 1997, v. 132, n. 4, p. 361, doi. 10.1007/s002130050356
- By:
- Publication type:
- Article